FARALLON CAPITAL MANAGEMENT LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 198 filers reported holding NOVOCURE LTD in Q2 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2020$80,700,000
+6.4%
725,000
-39.6%
0.56%
+13.2%
Q2 2019$75,876,000
+50.0%
1,200,000
+14.3%
0.49%
+29.7%
Q1 2019$50,579,000
+20.9%
1,050,000
-16.0%
0.38%
+23.8%
Q4 2018$41,850,000
-40.8%
1,250,000
-7.4%
0.31%
-26.6%
Q3 2018$70,740,000
+42.1%
1,350,000
-15.1%
0.42%
+36.2%
Q2 2018$49,767,000
+23.4%
1,590,000
-14.1%
0.31%
+10.0%
Q1 2018$40,330,000
+71.4%
1,850,000
+58.8%
0.28%
+46.1%
Q4 2017$23,533,0001,165,0000.19%
Other shareholders
NOVOCURE LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders